- Home
- INLX vs INMB Comparison
INLX vs INMB Comparison
Compare INLX & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INLX | INMB |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9M | 34.3M |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | INLX | INMB |
|---|---|---|
| Price | $7.00 | $1.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 879.0 | ★ 277.4K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | $11,336.00 | ★ $50,000.00 |
| Revenue This Year | $16.86 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $6.90 | $1.09 |
| 52 Week High | $15.00 | $11.64 |
Technical Indicators
Market Signals| Indicator | INLX | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 56.30 |
| Support Level | N/A | $1.40 |
| Resistance Level | $7.95 | $1.48 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 9.52 | 72.79 |
Price Performance
Historical ComparisonAbout INLX Intellinetics Inc.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.